Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Apr 22;5(4):e10304.
doi: 10.1371/journal.pone.0010304.

FAM-MDR: a flexible family-based multifactor dimensionality reduction technique to detect epistasis using related individuals

Affiliations

FAM-MDR: a flexible family-based multifactor dimensionality reduction technique to detect epistasis using related individuals

Tom Cattaert et al. PLoS One. .

Abstract

We propose a novel multifactor dimensionality reduction method for epistasis detection in small or extended pedigrees, FAM-MDR. It combines features of the Genome-wide Rapid Association using Mixed Model And Regression approach (GRAMMAR) with Model-Based MDR (MB-MDR). We focus on continuous traits, although the method is general and can be used for outcomes of any type, including binary and censored traits. When comparing FAM-MDR with Pedigree-based Generalized MDR (PGMDR), which is a generalization of Multifactor Dimensionality Reduction (MDR) to continuous traits and related individuals, FAM-MDR was found to outperform PGMDR in terms of power, in most of the considered simulated scenarios. Additional simulations revealed that PGMDR does not appropriately deal with multiple testing and consequently gives rise to overly optimistic results. FAM-MDR adequately deals with multiple testing in epistasis screens and is in contrast rather conservative, by construction. Furthermore, simulations show that correcting for lower order (main) effects is of utmost importance when claiming epistasis. As Type 2 Diabetes Mellitus (T2DM) is a complex phenotype likely influenced by gene-gene interactions, we applied FAM-MDR to examine data on glucose area-under-the-curve (GAUC), an endophenotype of T2DM for which multiple independent genetic associations have been observed, in the Amish Family Diabetes Study (AFDS). This application reveals that FAM-MDR makes more efficient use of the available data than PGMDR and can deal with multi-generational pedigrees more easily. In conclusion, we have validated FAM-MDR and compared it to PGMDR, the current state-of-the-art MDR method for family data, using both simulations and a practical dataset. FAM-MDR is found to outperform PGMDR in that it handles the multiple testing issue more correctly, has increased power, and efficiently uses all available information.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Summary of the steps involved in a FAM-MDR analysis.
The figure shows the three steps of FAM-MDR Part II on one of the simulated datasets for Model M27, formula image, formula image and formula image, for the analysis without main effects correction.
Figure 2
Figure 2. Probability-probability plots based on 100 replicates under the complete null hypothesis of no association.
Data are generated with no main effects and no two-way interaction effects, with formula image and formula image. Analyses are performed without correction for main effects. The first three panels show results of FAM-MDR (A), FAM-MDR* (B) and PGMDR (C) for the usual situation study considering 10 SNPs. The final panel (D) shows PGMDR results when only 2 SNPs are considered. The straight lines indicate the theoretical probability-probability curve (light blue) and the 5% significance level (dark blue).
Figure 3
Figure 3. Power of FAM-MDR and PGMDR based on 100 replicates, with .
The different panels show results for M27 (A) and M170 (B). Abbreviations: Corr. = with main effects correction, No Corr. = without main effects correction.

References

    1. Frazer KA, Ballinger DG, Cox DR, Hinds DA, Stuve LL, et al. A second generation human haplotype map of over 3.1 million SNPs. Nature. 2007;449:851–861. - PMC - PubMed
    1. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A. 2009;106:9362–9367. - PMC - PubMed
    1. Manolio TA, Brooks LD, Collins FS. A HapMap harvest of insights into the genetics of common disease. J Clin Invest. 2008;118:1590–1605. - PMC - PubMed
    1. Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet. 2008;40:955–962. - PMC - PubMed
    1. Dixon MS, Golstein C, Thomas CM, van Der Biezen EA, Jones JD. Genetic complexity of pathogen perception by plants: the example of Rcr3, a tomato gene required specifically by Cf-2. Proc Natl Acad Sci U S A. 2000;97:8807–8814. - PMC - PubMed

Publication types